Table 11.
Summary of ipsilateral lesion histopathology at biopsy for 67 additional ipsilateral lesions
| Histopathology | Lesion N (%) | PEM sensitivity (%) | MRI sensitivity (%) |
|---|---|---|---|
| N = 67 | |||
| Invasive and in situ carcinoma | 40 (60) | 34 (85) | 39 (98) |
| IDC | 18 (27) | 16 (89) | 18 (100) |
| ILC/ITLC | 5 (8) | 2 (40) | 4 (80) |
| IDC/ILC/DCIS | 1 (2) | 1 (100) | 1 (100) |
| IDC/DCIS | 10 (15) | 10 (100) | 10 (100) |
| DCIS | 6 (9) | 5 (83) | 6 (100) |
| High risk | 2 (3) | 1 (50) | 1 (50) |
| ADH | 2 (3) | 1 (50) | 1 (50) |
| Benign | 25 (37) | 6 (24) | 16 (64) |
| BBT | 3 (5) | 0 (0) | 0 (0) |
| FA | 7 (10) | 3 (43) | 5 (71) |
| FCC | 15 (22) | 3 (20) | 8 (53) |
IDC invasive/infiltrating ductal carcinoma; DCIS ductal carcinoma in situ; ILC invasive lobular carcinoma; ITLC invasive tubule-lobular carcinoma; ADH atypical ductal hyperplasia; BBT benign breast tissue; FA fibroadenoma; FCC fibrocystic change